Acton, MA, United States of America

Yihong Zhang

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yihong Zhang: Innovator in Fibronectin Based Scaffold Proteins

Introduction

Yihong Zhang is a notable inventor based in Acton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of fibronectin based scaffold proteins. With a total of 3 patents to his name, Zhang's work has implications in various diagnostic, research, and therapeutic applications.

Latest Patents

Zhang's latest patents focus on fibronectin based scaffold proteins that exhibit improved stability. The applications provide formulations of these proteins that are stable and can be utilized in a range of applications. Additionally, the patents cover cells that incorporate these proteins, as well as polynucleotides that encode the proteins or their fragments. The innovative nature of these patents highlights Zhang's commitment to advancing the field of biotechnology.

Career Highlights

Yihong Zhang is currently associated with Bristol-Myers Squibb Company, where he continues to contribute to groundbreaking research and development. His work is pivotal in enhancing the stability and functionality of fibronectin based scaffold proteins, which are essential in various biomedical applications.

Collaborations

Zhang has collaborated with notable colleagues such as Ray Camphausen and John O'Loughlin. These collaborations have further enriched his research and have led to advancements in the field.

Conclusion

Yihong Zhang's innovative work in fibronectin based scaffold proteins underscores his role as a leading inventor in biotechnology. His contributions are paving the way for new advancements in diagnostic and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…